Test Code LALB Lysosomal Acid Lipase, Blood
Useful For
Evaluation of patients with a clinical presentation suggestive of lysosomal acid lipase deficiency using blood specimens
This test is not useful to determine carrier status for cholesteryl ester storage disease or Wolman disease.
Special Instructions
Reporting Name
Lysosomal Acid Lipase, BSpecimen Type
Whole bloodSpecimen Required
Container/Tube:
Preferred: Lavender top (EDTA)
Acceptable: Yellow top (ACD) or green top (sodium heparin)
Specimen Volume: 2 mL
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Whole blood | Refrigerated (preferred) | 7 days | |
Ambient | 7 days |
Reference Values
≥21.0 nmol/h/mL
Interpretation
Enzyme activity below 1.5 nmol/h/mL in properly submitted samples is consistent with lysosomal acid lipase deficiency: Wolman disease or cholesteryl ester storage disease.
Normal results (≥21.0 nmol/h/mL) are not consistent with lysosomal acid lipase deficiency.
Clinical Reference
1. Bernstein DL, Hulkova H, Bialer MG, Desnick RJ. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol. 2013;58(6):1230-1243
2. Reynolds T. Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis. J Clin Pathol. 201366(11):918-923
3. Pericleous M, Kelly C, Wang T, Livingstone C, Ala A. Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol Hepatol. 2017;2(9):670-679. doi:10.1016/S2468-1253(17)30052-3
4. Pastores GM, Hughes DA: Lysosomal acid lipase deficiency. Therapeutic options. Drug Des Devel Ther. 2020;14:591-601
Day(s) Performed
Friday
Report Available
8 to 15 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82657
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
LALB | Lysosomal Acid Lipase, B | 73958-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
62954 | Lysosomal Acid Lipase, B | 73958-1 |
36339 | Reviewed By | 18771-6 |
36338 | Interpretation (LALB) | 59462-2 |
Method Name
Fluorometric Enzyme Assay
Forms
1. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available:
-Informed Consent for Genetic Testing (T576)
-Informed Consent for Genetic Testing-Spanish (T826)
2. Biochemical Genetics Patient Information (T602)
3. If not ordering electronically, complete, print, and send 1 of the following forms with the specimen: